C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.
about
The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptorsDendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine productionLong circulating lectin conjugated paclitaxel loaded magnetic nanoparticles: a new theranostic avenue for leukemia therapyIBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CAIdentification of CLEC12B, an inhibitory receptor on myeloid cells.Enhanced ADCC activity of affinity maturated and Fc-engineered mini-antibodies directed against the AML stem cell antigen CD96.Antibody blockade of CLEC12A delays EAE onset and attenuates disease severity by impairing myeloid cell CNS infiltration and restoring positive immunity.Identification of heptapeptides interacting with IFN-α-sensitive CML cells.Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicinIdentification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia.Inhibitory C-type lectin receptors in myeloid cells.Right on target: eradicating leukemic stem cells.Selection strategies for anticancer antibody discovery: searching off the beaten path.Signaling by myeloid C-type lectin receptors in immunity and homeostasisC-type lectin-like receptors on myeloid cells.Can immunotherapy specifically target acute myeloid leukemic stem cells?Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand.Targeting the leukemic stem cell: the Holy Grail of leukemia therapyNormal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia.Understanding of leukemic stem cells and their clinical implications.Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.CD123 targeting oncolytic adenoviruses suppress acute myeloid leukemia cell proliferation in vitro and in vivo.CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo.Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells.Recent advances in acute myeloid leukemia stem cell biologyAcute myelogenous leukemia stem cells: from Bench to Bedside.Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission--methodologies in relation to their clinical situation.The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia.TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.Targeting antigens to dendritic cell receptors for vaccine developmentModulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications.Recent developments in immunotherapy of acute myeloid leukemia.An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia.Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemiaAntibody-Based Treatment of Acute Myeloid Leukemia.Acute myeloid leukemia targets for bispecific antibodies.Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells.Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia.
P2860
Q24654154-435FCC84-620A-42DE-834B-FE49442FC47FQ24685926-B044C2D2-DB26-46E2-AB40-7DEDD2CF3EC6Q28477996-041663BD-A498-43AF-B248-790EB331E144Q28660580-AE78FBC3-ABD9-473E-A70A-B44820589A60Q30981925-5269C86B-896B-45D4-BB13-CD1968BEA6D3Q31083322-E38EF27B-BAE3-4E4F-BE7F-AA6DCC6D43DCQ33758969-982D4F3D-FF14-4123-A742-2845D74CC8DFQ34076524-2870C558-FD0C-4557-822F-1743B11C3B02Q34205189-219DB3B1-BA17-4F5B-B5AB-6E9DD150322CQ34232877-425B9337-8E80-4503-BCB3-59D0AA53ADB9Q34700805-7651FCA7-3C23-4CD3-AD34-015B0966FDFDQ35132225-5585BF26-31C6-4AAC-B7B9-848F0A2512DCQ35589427-B1EF00DF-3ACE-4E4A-9D50-4902A4EB8292Q35779708-339F6246-F43A-48AC-9037-70CA37D6F0BEQ36497532-8EF6CEEE-B8C8-4837-BCE3-74F6148F795CQ36694901-6907A0FE-AFC4-483B-90FA-D9CA46C64228Q36725571-45BB5052-316A-4B8C-AE70-6253502B304DQ37272565-3837F058-6AA6-419C-87BD-E149879BCFFDQ37297755-1138B23D-08A9-4810-A65E-F56ECAAC49C5Q37362705-A5468069-2063-43FA-8D2B-FD3731DF12D8Q37616010-61DDC15B-1265-4792-A201-63153F171295Q37628931-535480EE-82C8-4F92-9B50-7F87360CD620Q37679277-8E99B137-C7D6-481A-9D12-4589430E90E6Q37687139-1AD597FB-0A73-4D9E-A040-9EC737D1B321Q37809460-78C155F2-DA36-4B0E-A5D7-A8F687E19C31Q38003359-1011DCC4-3F11-475B-B40C-AD14B8773783Q38020081-29654147-2F14-4A22-A18B-01D84E204581Q38022075-EF5E6ED0-2076-4019-A02A-0EAE8A5E8E0CQ38025997-B2F85BA6-A047-4300-9530-DEFCF59FF731Q38035447-C4F32FA1-BC41-4D16-89D0-D8631B974697Q38138901-FE5522E5-FDDD-432C-8C63-5312A27C5CE0Q38162446-A3BC20B9-DCB0-4A4C-8395-E1211891AAC6Q38649946-72913BA6-9E32-4FE1-AD9C-56890ED6AC44Q38661895-9FB7CE67-57F8-48B1-9CD6-400D4319E402Q38727986-F444CEB1-CB42-4B2B-A76A-32712EB2A88FQ38972314-2AADD996-189D-405F-AE35-8DD9D0F6808EQ38979277-570CA192-154A-49E9-81EC-078C101C10B8Q39117761-8B818BB3-9FEF-438A-9814-D011318A3B95Q39422677-8746492C-E3DE-4750-92FB-FF434F37D6C1Q39817951-4D1FA170-8A40-4D57-82AB-09F7496E211B
P2860
C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.
@ast
C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.
@en
C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.
@nl
type
label
C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.
@ast
C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.
@en
C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.
@nl
prefLabel
C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.
@ast
C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.
@en
C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.
@nl
P2093
P1433
P1476
C-type lectin-like molecule-1: ...... d with acute myeloid leukemia.
@en
P2093
Ada M Kruisbeek
Alexander B H Bakker
Arjen Q Bakker
Cecilia A W Geuijen
Gerrit Jan Schuurhuis
Gert J Ossenkoppele
John de Kruif
Judith A Bia
Katarina Radosevic
Mandy A C Jongeneelen
P304
P356
10.1158/0008-5472.CAN-04-1659
P407
P577
2004-11-01T00:00:00Z